Medbelle raises $7m (€6m) in Series A to Build World’s First Digital Hospital
Funding round led by signals Venture Capital, with other investors including Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and prior backer Cavalry Ventures
Announcement signals rapid expansion of ground-breaking, end-to-end digital patient care platform
30,000 Britons have already used new service to navigate their treatment journey, as founders on target to attract a further 144,000 users by 2020
Medbelle bringing greater efficiency and transparency to the previously fragmented and bureaucratic healthcare sector
London and Berlin, April 2019 — Medbelle, the UK’s leading end-to-end platform for medical procedures, today announced $7m (€6m) in funding to accelerate the digitisation of the patient journey. The Series A funding round was led by signals Venture Capital and joined by Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and Cavalry Ventures.
Already covering the majority of the UK, and with its eye on international expansion, Medbelle’s three-layered ‘digital hospital’ model (Medbelle Platform, Medbelle Care, and Medbelle Operating System) places unprecedented control in the hands of patients, while giving healthcare professionals access to an integrated suite of management tools covering the entire treatment journey – from first consultation to billing, post-operative care and follow-up.
Patients book their procedure with Medbelle, which provides them with leading specialists and state-of-the-art operating facilities – with all organisation taken care of by the platform. The Medbelle service is designed to save them time, stress and money, ensuring that they benefit from the very best treatments and facilities available. Once a patient is registered, every aspect of their treatment is accessible via a single, simple web portal and app, or through their own personal Medbelle Care Adviser.
At the same time, the Medbelle Operating System ensures healthcare providers can make the most of their valuable time and resources. It allows specialists, hospitals and staff to work more productively, and liberates them from inefficient, unnecessary administrative tasks.
Already enthusiastically backed by patients, with an outstanding Net Promoter Score (NPS) of 93 – making it the highest-rated medical provider in the UK – the cash injection will enable Medbelle to undertake the next phase of its roll-out. And with the UK private healthcare sector forecast to hit $13.8bn by 2023, it’s a market opportunity that has proven highly attractive to investors.
In its launch phase, Medbelle was focused on privately-paid (self-funded) procedures in areas such as cosmetics, bariatrics and ophthalmology and is currently expanding into orthopaedics and fertility. In the future, Medbelle will work with private medical and public insurance providers / the NHS to leverage its technology and services to help patients with all types of medical procedure.
“The new capital will accelerate the development of our platform while growing Medbelle’s operating footprint,” said Daniel Kolb, co-founder and MD of Medbelle. “It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients.”
Clemens Koós, investment manager at signals Venture Capital, said: “Major digital platforms improve customer experience in almost all industries, however, in healthcare, the digitisation of patient journeys has been heavily lagging behind until now. Medbelle’s technology and personalised care enable much simpler and more affordable medical treatments - while allowing healthcare providers to efficiently focus on treating patients. We look forward to working with the Medbelle team and co-investors in expanding the platform to include more treatment specialities and increasing its reach."
Vasile Foca, Managing Partner at Talis Capital, said: “The digital health market is expected to reach $536bn by 2025 – so the time is right to be focusing on technologies that can transform healthcare and the patient journey as we know it today. We’re proud to be backing Leander, Daniel and their high-quality team in this latest round as they roll out their truly digital treatment solution. Medbelle is the world’s first digital hospital that creates real value for both patients and providers and offers unrivalled care from some of the country’s best specialists.”
Leander de Laporte, co-founder and MD at Medbelle, said: “The ‘digital hospital’ creates real value for patients and healthcare providers alike and, therefore, can offer care from the best specialists in the country with a truly digital and personal experience. It’s great to have new partners on board who bring such vast experience to the table. We all agree that an integrated model enables much faster deployment of technology to improve patient experience and reduce costs.”